# A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

> **NCT05657873** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 68 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- Non-small Cell Carcinoma
- NSCLC
- NSCLC Stage IV

## Interventions

- **RADIATION:** L-SABR
- **BIOLOGICAL:** Anti-PD-(L)1 based immunotherapy
- **DRUG:** Platinum based chemotherapy

## Key facts

- **NCT ID:** NCT05657873
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-09
- **Primary completion:** 2026-12-09
- **Final completion:** 2026-12-09
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05657873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05657873, "A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-09-19 from https://api.ai-analytics.org/clinical/NCT05657873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*